RG
ELV icon

Redmile Group’s Elevance Health ELV Stock Holding History

Redmile Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-31,223
Closed -$16.2M – 70
2024
Q1 		$16.2M Buy
31,223
+8,144
+35% +$4.05M 0.59% 43
2023
Q4 		$10.9M Sell
23,079
-62,299
-73% -$28.8M 0.39% 50
2023
Q3 		$37.2M Buy
85,378
+7,065
+9% +$3.2M 1.77% 17
2023
Q2 		$34.8M Buy
78,313
+11,915
+18% +$5.5M 1.34% 24
2023
Q1 		$30.5M Buy
66,398
+27,428
+70% +$13.1M 1.32% 29
2022
Q4 		$20M Sell
38,970
-31,517
-45% -$16M 0.82% 36
2022
Q3 		$32M Sell
70,487
-13,500
-16% -$6.46M 1.24% 26
2022
Q2 		$40.5M Buy
83,987
+825
+1% +$408K 1.55% 20
2022
Q1 		$40.9M Sell
83,162
-27,127
-25% -$12.4M 1.28% 24
2021
Q4 		$51.1M Sell
110,289
-17,213
-14% -$7.24M 1.16% 27
2021
Q3 		$47.5M Buy
127,502
+18,701
+17% +$7.11M 0.83% 39
2021
Q2 		$41.5M Sell
108,801
-21,604
-17% -$8.26M 0.61% 45
2021
Q1 		$46.8M Sell
130,405
-113,927
-47% -$36.6M 0.66% 45
2020
Q4 		$78.5M Buy
+244,332
New +$75M 0.95% 36
2020
Q1 		– Sell
-100,800
Closed -$30.4M – 72
2019
Q4 		$30.4M Buy
+100,800
New +$27.7M 0.73% 35
2019
Q3 		– Sell
-183,500
Closed -$51.8M – 79
2019
Q2 		$51.8M Buy
183,500
+6,800
+4% +$1.86M 1.47% 20
2019
Q1 		$50.7M Buy
176,700
+61,200
+53% +$17.7M 1.48% 21
2018
Q4 		$30.3M Sell
115,500
-118,500
-51% -$32.6M 1.22% 28
2018
Q3 		$64.1M Buy
234,000
+88,000
+60% +$22.8M 1.97% 16
2018
Q2 		$34.8M Buy
+146,000
New +$33.8M 1.18% 31
2017
Q3 		– Sell
-231,886
Closed -$43.6M – 69
2017
Q2 		$43.6M Buy
231,886
+56,558
+32% +$10.2M 2.66% 10
2017
Q1 		$29M Buy
175,328
+98,105
+127% +$15.6M 1.88% 20
2016
Q4 		$11.1M Buy
+77,223
New +$10.3M 0.96% 29

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Redmile Group's ELV Position: Q2 2024 in Review

Redmile Group sold out of Elevance Health (ELV) in Q2 2024, closing a stake of 31,223 shares — an estimated $16.2M sold.

Redmile Group first reported a position in ELV in Q4 2016 and held it in 23 quarters. The position peaked at $78.5M in Q4 2020. 1,705 funds tracked by Wall St. Rank hold ELV as of Q2 2024.

  • Redmile Group reported no remaining Elevance Health position as of Q2 2024 after selling out during the quarter.
  • Redmile Group sold 31,223 Elevance Health shares in Q2 2024, an estimated $16.2M.
  • Redmile Group first reported a position in Elevance Health in Q4 2016 and held it in 23 quarters.
  • Redmile Group's Elevance Health position peaked at $78.5M in Q4 2020.
  • 1,705 funds tracked by Wall St. Rank held Elevance Health as of Q2 2024.

Based on Redmile Group's 13F filing for Q2 2024, filed 14 Aug 2024.